Viewing Study NCT03193333


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-01-09 @ 3:07 PM
Study NCT ID: NCT03193333
Status: TERMINATED
Last Update Posted: 2025-03-06
First Post: 2017-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)
Sponsor: Laboratorios Sophia S.A de C.V.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Open-angle Glaucoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ophthalmic antihypertensives View
None glaucoma View
None primary open-angle glaucoma View
None Krytantek Ofteno®. View
None timolol View
None brimonidine View
None dorzolamide View